BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2786540)

  • 1. [Serological and immunohistochemical studies in pregnant women with systemic lupus erythematosus].
    Sakui H; Yoshimura Y; Tada S; Tateyama Y; Shiraki M; Kokubo M; Torikai K; Kawakami S; Fukushima M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):249-56. PubMed ID: 2786540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum complement levels and perinatal outcome in pregnancies complicated by systemic lupus erythematosus.
    Devoe LD; Loy GL
    Obstet Gynecol; 1984 Jun; 63(6):796-800. PubMed ID: 6728360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies of the placenta in systemic lupus erythematosus.
    Grennan DM; McCormick JN; Wojtacha D; Carty M; Behan W
    Ann Rheum Dis; 1978 Apr; 37(2):129-34. PubMed ID: 348129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus.
    Clowse ME; Magder LS; Petri M
    J Rheumatol; 2011 Jun; 38(6):1012-6. PubMed ID: 21406496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus.
    el-Roeiy A; Gleicher N; Isenberg D; Kennedy RC; Shoenfeld Y
    Clin Exp Immunol; 1987 Jun; 68(3):528-34. PubMed ID: 3115649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus erythematosus, the placenta, and pregnancy: a natural experiment in immunologically mediated reproductive failure.
    Abramowsky CR
    Prog Clin Biol Res; 1981; 70():309-20. PubMed ID: 7031694
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
    Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
    Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental abnormalities in systemic lupus erythematosus: in situ deposition of antinuclear antibodies.
    Guzman L; Avalos E; Ortiz R; Gurrola R; Lopez E; Herrera R
    J Rheumatol; 1987 Oct; 14(5):924-9. PubMed ID: 2963129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
    Cohen D; Buurma A; Goemaere NN; Girardi G; le Cessie S; Scherjon S; Bloemenkamp KW; de Heer E; Bruijn JA; Bajema IM
    J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus. Management during pregnancy.
    Zurier RB; Argyros TG; Urman JD; Warren J; Rothfield NF
    Obstet Gynecol; 1978 Feb; 51(2):178-80. PubMed ID: 304545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy.
    Mendonca LL; Khamashta MA; Cuadrado MJ; Bertolaccini ML; Hughes GR
    Arthritis Rheum; 2000 Jul; 43(7):1511-5. PubMed ID: 10902753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.
    Leaños-Miranda A; Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Parra A; Ramírez-Peredo J
    Lupus; 2007; 16(5):342-9. PubMed ID: 17576736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.
    Ludivico CL; Zweiman B; Myers AR; Hebert J; Green PA
    J Rheumatol; 1980; 7(6):843-9. PubMed ID: 6970815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.
    Lockshin MD; Druzin ML; Goei S; Qamar T; Magid MS; Jovanovic L; Ferenc M
    N Engl J Med; 1985 Jul; 313(3):152-6. PubMed ID: 3925336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
    Sun L; Wang D; Liang J; Zhang H; Feng X; Wang H; Hua B; Liu B; Ye S; Hu X; Xu W; Zeng X; Hou Y; Gilkeson GS; Silver RM; Lu L; Shi S
    Arthritis Rheum; 2010 Aug; 62(8):2467-75. PubMed ID: 20506343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of autoimmunity in progeny of pregnant women with systemic lupus erythematosus].
    Tong X; Pan W; Hong S
    Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):143-6. PubMed ID: 11263182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.